收藏本站
热门搜索: A3500  E1910  A1360  25200056  dmem  

对甲苯胺蓝(BCIP)5-Bromo-4-Chloro-3-Indolyl Phosphate

 
包装: 25 mg
运保温度: -20°C
到货周期: 登录后查看
标准价: ¥客户可见
会员价: ¥客户可见
积分: 客户可见
 
登录之后可加入购物车购买,请您 
对比 收藏

运费与支付说明:

1.含干冰类产品有运费;

2. 必须现金付款或有信用额度的会员才可以直接发货,否则需要等待现金付款信息。

描述:

5-Bromo-4-chloro-3-indolylphosphate
Catalog Number: 100368, 150042, 193989, 193991

Molecular Biology Reagent
p-Toluidine Salt
Purity: ≥98%
A chromogenic substrate for alkaline phosphatase in ELISA.
 


Structure:
 

 

Sodium Salt p-Toluidine Salt
Molecular Formula: C8H4BrClNO4PNa2 Molecular Formula: C8H6BrClNO4P · C7H9N
Molecular Weight: 370.4 Molecular Weight: 433.7
CAS # : 102185-33-1 CAS # : 6578-06-9

Synonyms: BCIP; X-phosphate

Physical Description: White to off-white powder

Purity: >98%

Description: A chromogenic substrate for alkaline phosphatase.

Typical Procedure for the Detection of Alkaline Phosphatase using a NBT/BCIP System:

Nitro Blue Tetrazolium (NBT) is used with the alkaline phosphatase substrate BCIP in immunostaining1 and immunohistological4staining procedures. This substrate system produces an insoluble NBT diformazan end product that is blue in color and can be observed visually.

During the reaction tautomerization of the BCIP occurs, which under alkaline conditions, results in dimerization of the BCIP. The hydrogen ions released during dimerization cause reduction of NBT yielding the insoluble NBT diformazan product.

Use a substrate buffer consisting of 0.1 M Tris, 100 mM sodium chloride, 5 mM MgCl2, pH 9.5, adjust the pH with HCl.

Add 33 ul of a 50 mg/ml stock solution of BCIP in water and 330 ul of a 10 mg/ml NBT stock solution in water to 10 ml of substrate buffer.

Rinse specimens incubated with an alkaline phosphatase conjugate in a wash buffer (non-phosphate) before treatment with the BCIP/NBT substrate solution. Cover the entire specimen with the reagent during color development. Incubate the specimen at room temperature with theh BCIP/NBT reagent for approximately 10 minutes. Specimens and procedure may affect the length of time needed for color development. Monitor the color development to avoid over-development. Stop the color development by rinsing the specimen with distilled water.

Troubleshooting the procedure:

1. Background is too high:
 

    a. Use a blocking step prior to the application of the primary antibody. Normal serum (10% v/v) from the same species as the second antibody generally produces the best results.
    b. Additional blocking agents for immunoblotting are 10% BSA, 0.05% Tween 20, or 3% Non-fat dried milk powder; however, do not use the dried milk when using an avidin-biotin system.
    c. Decrease staining time.
    d. Titer the conjugate to optimize working dilution.


2. No color develops or color is too faint:
 

    a. Adjust the concentration of the primary antibody.
    b. Adjust the concentration of the secondary antibody.
    c. Determine if the enzyme conjugate is active.
    d. Consider using an amplifying system such as avidin-biotin.
    e. Increase the staining time.
    f. Adjust the transfer time of the samples to the nitrocellulose membrane.
    g. Increase the amount of sample.


Solubility: Disodium salt is soluble in water (50 mg/ml); insoluble in dimethylformamide. The p-Toluidine salt is soluble in DMF (20 mg/ml) but insoluble in water. The most common buffer to use with BCIP and alkaline phosphatase is 0.1 M Tris, 100 mM NaCl, 5 mM MgCl2, pH 9.5. Solutions should be prepared fresh for each use.

Solubility (of toluidine salt): Soluble in 1 N Sodium Hydroxide (0.5% w/v); DMF (1%-clear, slightly yellowish solution); insoluble in water


Availability:



Catalog Number Description Size
150042 5-Bromo-4-chloro-3-indolyl phosphate, disodium salt 50 mg
100 mg
250 mg
1 g
193989 5-Bromo-4-chloro-3-indolyl phosphate, disodium salt, molecular biology reagent 100 mg
500 mg
100368 5-Bromo-4-chloro-3-indolyl phosphate, p-Toluidine salt 25 mg
50 mg
100 mg
1 g
193991 5-Bromo-4-chloro-3-indolyl phosphate, p-Toluidine salt, molecular biology reagent 25 mg
100 mg
500 mg

Also Available:



Catalog Number Description Size
980781
980782
BCIP, stabilized substrate, ready-to-use; concentration 2.31 mmol/liter 100 ml
500 ml
100416 p-Nitro Blue Tetrazolium Chloride 50 mg
100 mg
250 mg
500 mg
1 g
5 g
193999 p-Nitro Blue Tetrazolium Chloride, molecular biology reagent 50 mg
250 mg
1 g
980791
980792
p-Nitro Blue Tetrazolium Liquid Substrate, stabilized substrate solution, ready-to-use; concentration 0.489 mmol/liter 100 ml
500 ml

References:
 

  1. Blake, M.S., Anal. Biochem., v. 136, 175 (1984).
  2. Ey, P.L. and Ashman, L.K., Meths. Enzymol., v. 121, 497 (1986).
  3. Fikrig, S.M., et al., The Lancet, Sept. 7, p. 532 (1968).
  4. Horowitz, J.P., et al., J. Med. Chem., v. 9, 447 (1966).
  5. Knecht, D.A. and Dimond, R.L., "Visualization of antigenic proteins on Western blots." Anal. Biochem., v. 136:1, 180-184 (1984).
  6. Leary, J.J., et al., "Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: Bioblots." Proc. Natl. Acad. Sci., v. 80, 4045-4049 (1983).
  7. McGadey, J., "A tetrazolium method for non-specific alkaline phosphatase." Histochemie., v. 23, 180-184 (1970).
  8. Meltzer, J.C., et al., "Enhanced immunohistochemical detection of autonomic nerve fibers, cytokines and inducible nitric oxide synthase by light and fluorescent microscopy in rat spleen." J. Histochem. Cytochem., v. 45:4, 599-610 (1997).
  9. Walters, C., et al., "Detection of parvovirus B19 in macerated fetal tissue using in situ hybridisation." J. Clin. Pathol., v. 50:9, 749-754 (1997).


 


相关图片

参考文献

本产品可用于的实验

购此产品的人还购买了

京ICP备15036693号-2    京公网安备11010802025653    版权所有:北京逸优科技有限公司       0.04

 纠 错